marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-07-2024
DiaMedica Therapeutics Financial Statements 2011-2024 | DMAC
Annual Financial Statements DiaMedica Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
91.8 M | 42 M | 53.8 M | 134 M | 49.9 M | 29.6 M | 27.3 M | 12 M | 7.92 M | 2.98 M | 44.3 M | 48.5 M | - |
Shares |
32.6 M | 26.4 M | 20.8 M | 16.7 M | 12 M | 7.74 M | 5.94 M | 4.74 M | 3.62 M | 3.04 M | 2.73 M | 2.45 M | - |
Historical Prices |
2.82 | 1.59 | 2.59 | 8.03 | 4.36 | 3.9 | 5.36 | 2.28 | 2.18 | 0.98 | 16.2 | 19.8 | - |
Net Income |
-19.4 M | -13.7 M | -13.6 M | -12.3 M | -10.6 M | -5.73 M | -4.26 M | -2.22 M | -1.44 M | -4.82 M | -7.41 M | -10.1 M | -6.61 M |
Revenue |
- | - | - | - | - | 500 K | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-21.3 M | -14 M | -13.6 M | -12.7 M | -11.6 M | -6.76 M | -4.52 M | - | - | - | - | - | - |
Interest Expense |
1.93 M | 353 K | 82 K | 229 K | 119 K | -68 K | 6 K | - | - | - | - | - | - |
EBITDA |
-21.2 M | -14 M | -13.6 M | -12.5 M | -10.7 M | -5.53 M | -4.28 M | -2.26 M | -1.39 M | -4.83 M | -6.32 M | -7.7 M | -4.35 M |
Operating Expenses |
21.3 M | 14 M | 13.6 M | 12.5 M | 10.7 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.16 M | 6.16 M | 4.88 M | 4.39 M | 3.69 M | 2.74 M | 1.31 M | 718 K | 423 K | 1.12 M | 2.54 M | 2.53 M | 2.08 M |
All numbers in USD currency
Quarterly Income Statement DiaMedica Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
38.1 M | 38 M | 38 M | 37.9 M | 27.3 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 19 M | 18.8 M | 18.8 M | 18.7 M | 16.7 M | 14.1 M | 13.1 M | 12 M | 12 M | 12 M | 12 M | 12 M | 7.84 M | 7.82 M | 6.55 M | 6.37 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.12 M | -5.15 M | - | -4.47 M | -4.48 M | -5.27 M | - | -3.06 M | -3.36 M | -3.51 M | - | -3.45 M | -3.27 M | -3.62 M | - | -3.19 M | -2.47 M | -2.42 M | - | -2.45 M | -2.47 M | -3.25 M | - | -1.39 M | -1.74 M | -650 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 500 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.64 M | -5.74 M | - | -5.16 M | -4.74 M | -5.52 M | - | -3.13 M | -3.36 M | -3.54 M | - | -3.42 M | -3.36 M | -3.62 M | - | -3.32 M | -2.71 M | -2.4 M | - | -2.66 M | -2.74 M | -3.42 M | - | -1.49 M | -1.85 M | -1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
526 K | 597 K | - | 693 K | 271 K | 256 K | - | 76 K | 13 K | 35 K | - | -27 K | 98 K | 4 K | - | 103 K | 178 K | -127 K | - | -38 K | 54 K | 4 K | - | -39 K | 13 K | -35 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -5.73 M | - | - | - | -5.51 M | - | -3.11 M | -3.35 M | -3.53 M | - | -3.4 M | -3.35 M | -3.61 M | - | -3.3 M | -2.7 M | -2.4 M | - | -2.64 M | -2.73 M | -3.42 M | - | -1.48 M | -1.84 M | -1.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.42 M | - | - | - | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.71 M | 2.06 M | - | 1.88 M | 2.2 M | 1.9 M | - | 1.49 M | 1.41 M | 1.56 M | - | 1.08 M | 1.21 M | 1.21 M | - | 1.16 M | 1.11 M | 1.06 M | - | 1.04 M | 867 K | 814 K | - | 777 K | 780 K | 515 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency